TIMP1 and coronary artery disorder: In the prospective AtheroGene study (n = 1979), levels of TIMP-1 (HR 1.30, 95% CI, 1.07–1.58), hsCRP (HR 1.79, 95% CI, 1.43–2.24), and B-type natriuretic peptide (HR 2.75, 95% CI, 1.94–3.89) were independently associated with cardiovascular death in CAD patients [23].